Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07269808 · ClinicalTrials.gov registry record · Phase 3
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
A Phase 3 study of Anesthesia and Sedation, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07269808: Recruiting Phase 3 study of Anesthesia and Sedation, sponsored by Massachusetts General Hospital.
NCT07269808 is a Phase 3 study of Anesthesia and Sedation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07269808, a Phase 3 study of Anesthesia and Sedation, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
Primary Outcome
Counts the number of patients screened who meet all prespecified inclusion and exclusion criteria for trial eligibility.
Conditions Studied
Interventions
- DRUG Remimazolam
- DRUG Propofol
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 3 |
What NCT07269808 shows while recruiting
NCT07269808 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Remimazolam is the first listed.
NCT07269808 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07269808 about?
NCT07269808 is a clinical study titled "Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration". This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
What is the current status of trial NCT07269808?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2026-03-03. Estimated completion is 2026-06-01.
What conditions does trial NCT07269808 study?
This clinical trial studies the following conditions: Anesthesia, Sedation, Endoscopy.
What interventions are being tested in trial NCT07269808?
The interventions under investigation include: Remimazolam (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT07269808?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07269808 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07269808's enrollment target sits among peer trials
100 17th of 57 higher than 39 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
RECRUITING · Phase 3
-
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
ACTIVE NOT RECRUITING · Phase 3
-
Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables
COMPLETED · Phase 3
-
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
COMPLETED · Phase 3
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI